Sabine Louët is the Editor of the Euroscientist since 2013. You are welcome to contact Sabine, should you have any suggestions for articles or if you are interested in writing a guest post for this magazine.
The Marie Curie Alumni Association, in collaboration with EuroScientist, will be hosting a round table about overcoming EU countries’ inequalities in science in the European Research Area. Please join this webinar and learn more about what needs to be done to counter the imbalance in the research system in Europe. The debate will be focused on the present differences in funding within European countries and within Europe. Read more […]
Diabetes is one of the largest global health emergencies of the 21st century. On a global scale, there are an estimated 415 million people aged 20-79 with diabetes. These include 193 million who are undiagnosed. A further 318 million adults with impaired glucose tolerance are also at high risk of developing the disease. In 2015 alone, diabetes and its related complications will have caused 5 million deathsand cost 12% of the global healthcare spend. How can we slow, stop, or reverse the diabetes epidemic? Read more […]
Responsible Research and Innovation (RRI) is too often no more than a cryptic acronym to many in European research circles. It is at times not quite clear how to implement it. Now, thanks to the results of the RRI Tools project, an RRI Toolkit is about to be launched this week. Don’t hold back and feel free to explore all the available options. Read more […]
Despite advances in our understanding of management and prevention, chronic diseases are still on the rise. By 2030, estimates point that an additional 52 million people will die from chronic diseases. Public healthcare systems are under strain, and their budgets are getting smaller. How can we reverse the chronic disease epidemic? First and foremost, citizens can help themselves. Some governments in Europe have already tried to encourage healthier lifestyle choices. Is promoting healthy lifestyles authoritarian? Or is a government that fails to do so guilty of neglect? Read more […]
Since the last decade, wearable technology moved from developers’ drawing boards to stores, with barely a whisper of disquiet about data privacy. Yet, the implications for data privacy should not be underestimated. There is growing interest in the potential of wearables to mitigate, treat or prevent chronic conditions which put a strain on health economies–ranging from chronic back pain or physical stress injuries to mental health issues like work-related stress. EuroScientist investigates how the latest regulatory framework could secure people’s privacy as they strive to prevent chronic conditions through wearable technology. Read more […]
Thanks to advances in technology, the ubiquitous smartphone is not just a way to connect with friends. It also becomes a kind of “doctor in our pocket”. Health apps, wearable sensors and fitness trackers are all contributing towards ‘more and better data’ for monitoring everything from caloric intake to steps taken on a daily basis. If we want to better understand, manage, and prevent chronic diseases, then new technologies and innovations like these are vital. Read more […]
Alberto Alemanno, professor of law at French business school HEC Paris, shares his views on the more practical solutions available for the prevention of chronic diseases. He reveals that the solutions to such a complex problem are multiple and need to be combined to be effective. Read more […]
Over the next five weeks, EuroScientist is exploring new ways of interacting with the wider community of readers via a partnership with the REIsearch project. The idea is to focus the pan-European debate on themes of key importance in the European policy agenda. This week, we will start exploring the theme of chronic diseases. Click on banners on our site to complete a survey to share your perspective on this issue. We will also offer our readers independent coverage related to the topic and invite you to comment below each article. Read more […]
Public databases of the toxic effects of chemicals that have been registered under the REACH directive have been sitting idle for too long. In an opinion piece, Thomas Hartung explains how the development of software by his team at the Bloomberg School of Public Health, at Johns Hopkins University, USA, helps make sense of the large volume of chemical database content. Now that they made such data machine readable, expectations are that it will soon be possible to provide open access to such public database. Ultimately, this could substantially decrease the number of animal tests. Indeed, the database makes it possible to do so-called read-across, allowing to infer toxicity of heaps of untested chemicals from existing data on chemicals of similar structure, which have already been tested. Read more […]
This year we celebrate the 10th annoversary of the adoption of the UN Convention on the rights of persons with disabilities. We now observe new issues arising that no-one could have ever anticipated 10 years ago, which are currently not dealt with by the Convention. The potential for rehabilitation of persons with disabilities is such that now we can enhance our capabilities beyond those of people without disabilities. Read more […]
Welcome to this special issue of EuroScientist focusing on Gender issues in research and academia. We have asked the views of Nobel Laureates, who have an interesting perspective on women in science. You will also discover a wealth of opinions describing what remains to be done to resolve gender issues. Not only do we discuss ways of resolving conscious and unconscious gender bias, but we also look at issues related to how gender perspective affects the nature of research itself. As for solutions, it appears that mentoring is one of the most helpful solution, beyond more interventionist approaches such as quota, which are controversial. Read more […]
The issues women in science face are not new. Solutions borrowed from the corporate world or the field of politics such as quota could be a solution. There are also many more options to try and move the line between genders. EuroScientist would like to know what its readers think about quota. Could they challenge the quality of academic work? Read more […]
European science conversations by the community, for the community
